Regeneron Pharmaceuticals Inc. buy Luise1
Start price
21.06.15
/
50%
€463.80
Target price
21.12.15
€550.50
Performance (%)
9.26%
End price
21.12.15
€506.77
Summary
This prediction ended on 21.12.15 with a price of €506.77. With a performance of 9.26%, the BUY prediction by Luise1 for Regeneron Pharmaceuticals Inc. closed with a slight gain. Luise1 has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | -1.064% | -1.064% | 1.609% | -4.685% |
| iShares Core DAX® | -2,53 % | -5,19 % | 4,91 % | 52,00 % |
| iShares Nasdaq 100 | -0,03 % | 1,56 % | 21,79 % | 95,66 % |
| iShares Nikkei 225® | -4,20 % | -7,55 % | 31,13 % | 52,99 % |
| iShares S&P 500 | -0,80 % | 0,16 % | 15,78 % | 66,53 % |
Comments by Luise1 for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Biotech
ein spekulatives buy
(Laufzeit überschritten)